Conduction and refractory disorders in the diabetic atrium

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 303, Issue 1, 2012, Pages

  Watanabe, Masaya ^a   Yokoshiki, Hisashi ^a   Mitsuyama, Hirofumi ^a   Mizukami, Kazuya ^a   Ono, Taisuke ^a   Tsutsui, Hiroyuki ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Action potential duration; Atrial fibrillation; Conduction velocity; Diabetes mellitus; Optical mapping

Indexed keywords

GAP JUNCTION PROTEIN;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FIBROSING ALVEOLITIS; HEART ATRIUM; HEART ATRIUM PACING; HEART MUSCLE CONDUCTION DISTURBANCE; HEART PACING; HEART STIMULATION; HISTOPATHOLOGY; INCIDENCE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STREPTOZOCIN DIABETES; TACHYCARDIA; TISSUE REGENERATION;

ACTION POTENTIALS; ANIMALS; BLOOD GLUCOSE; BLOTTING, WESTERN; CARDIAC PACING, ARTIFICIAL; CONNEXINS; DATA INTERPRETATION, STATISTICAL; DIABETES MELLITUS, EXPERIMENTAL; ELECTRIC STIMULATION; ELECTROCARDIOGRAPHY; FIBROSIS; HEART; HEART ATRIA; HEART CONDUCTION SYSTEM; MALE; MYOCARDIUM; PERFUSION; RATS; RATS, WISTAR; REFRACTORY PERIOD, ELECTROPHYSIOLOGICAL; TACHYCARDIA;

EID: 84863635939     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00010.2012     Document Type: Article

References (35)

1. Allo SN, Lincoln TM, Wilson GL, Green FJ, Watanabe AM, Schaffer SW. Non-insulin-dependent diabetes-induced defects in cardiac cellular calcium regulation. Am J Physiol Cell Physiol 260: C1165-C1171, 1991.
2. Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med 14, Suppl 5: S1-S85, 1997.
3. Antzelevitch C, Sun ZQ, Zhang ZQ, Yan GX. Cellular and ionic mechanisms underlying erythromycin-induced long QT intervals and torsade de pointes. J Am Coll Cardiol 28: 1836-1848, 1996.
4. Bayly PV, KenKnight BH, Rogers JM, Hillsley RE, Ideker RE, Smith WM. Estimation of conduction velocity vector fields from epicardial mapping data. IEEE Trans Biomed Eng 45: 563-571, 1998.
5. Boutjdir M, Le Heuzey JY, Lavergne T, Chauvaud S, Guize L, Carpentier A, Peronneau P. Inhomogeneity of cellular refractoriness in human atrium: factor of arrhythmia? Pacing Clin Electrophysiol 9: 1095-1100, 1986.
6. Efimov IR, Nikolski VP, Salama G. Optical imaging of the heart. Circ Res 95: 21-33, 2004.
7. Fedorov VV, Lozinsky IT, Sosunov EA, Anyukhovsky EP, Rosen MR, Balke CW, Efimov IR. Application of blebbistatin as an excitationcontraction uncoupler for electrophysiologic study of rat and rabbit hearts. Heart rhythm 4: 619-626, 2007.
8. Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Metayer P, Clementy J. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 339: 659-666, 1998.
9. Harada M, Tsuji Y, Ishiguro YS, Takanari H, Okuno Y, Inden Y, Honjo H, Lee JK, Murohara T, Sakuma I, Kamiya K, Kodama I. Rate-dependent shortening of action potential duration increases ventricular vulnerability in failing rabbit heart. Am J Physiol Heart Circ Physiol 300: H565-H573, 2011.
10. Igarashi T, Finet JE, Takeuchi A, Fujino Y, Strom M, Greener ID, Rosenbaum DS, Donahue JK. Connexin gene transfer preserves conduction velocity and prevents atrial fibrillation. Circulation 125: 216-225, 2012.
11. Johnson JN, Tester DJ, Perry J, Salisbury BA, Reed CR, Ackerman MJ. Prevalence of early-onset atrial fibrillation in congenital long QT syndrome. Heart Rhythm 5: 704-709, 2008.
12. Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: populationbased estimates. Am J Cardiol 82: 2N-9N, 1998.
13. Kato T, Yamashita T, Sekiguchi A, Sagara K, Takamura M, Takata S, Kaneko S, Aizawa T, Fu LT. What are arrhythmogenic substrates in diabetic rat atria? J Cardiovasc Electrophysiol 17: 890-894, 2006.
14. Klem I, Wehinger C, Schneider B, Hartl E, Finsterer J, Stollberger C. Diabetic atrial fibrillation patients: mortality and risk for stroke or embolism during a 10-year follow-up. Diabetes Metab Res Rev 19: 320-328, 2003.
15. Koller ML, Riccio ML, Gilmour RF Jr. Dynamic restitution of action potential duration during electrical alternans and ventricular fibrillation. Am J Physiol Heart Circ Physiol 275: H1635-H1642, 1998.
16. Kostin S, Klein G, Szalay Z, Hein S, Bauer EP, Schaper J. Structural correlate of atrial fibrillation in human patients. Cardiovasc Res 54: 361-379, 2002.
17. Lammers WJ, Schalij MJ, Kirchhof CJ, Allessie MA. Quantification of spatial inhomogeneity in conduction and initiation of reentrant atrial arrhythmias. Am J Physiol Heart Circ Physiol 259: H1254-H1263, 1990.
18. Lau DH, Mackenzie L, Kelly DJ, Psaltis PJ, Worthington M, Rajendram A, Kelly DR, Nelson AJ, Zhang Y, Kuklik P, Brooks AG, Worthley SG, Faull RJ, Rao M, Edwards J, Saint DA, Sanders P. Short-term hypertension is associated with the development of atrial fibrillation substrate: a study in an ovine hypertensive model. Heart Rhythm 7: 396-404, 2010.
19. Lee KW, Everett THt Rahmutula D, Guerra JM, Wilson E, Ding C, Olgin JE. Pirfenidone prevents the development of a vulnerable substrate for atrial fibrillation in a canine model of heart failure. Circulation 114: 1703-1712, 2006.
20. channel (SK2 channel) results in action potential prolongation in atrial myocytes and atrial fibrillation. J Physiol 587: 1087-1100, 2009.
21. Murgatroyd FD, Camm AJ. Atrial arrhythmias. Lancet 341: 1317-1322, 1993.
22. Narayan SM, Franz MR, Clopton P, Pruvot EJ, Krummen DE. Repolarization alternans reveals vulnerability to human atrial fibrillation. Circulation 123: 2922-2930, 2011.
23. 2 -cycling proteins may underlie sarcoplasmic reticulum dysfunction in the diabetic heart. Diabetes 50: 2133-2138, 2001.
24. 2 channel. Cardiovasc Res 24: 381-389, 1990.
25. Nygren A, Olson ML, Chen KY, Emmett T, Kargacin G, Shimoni Y. Propagation of the cardiac impulse in the diabetic rat heart: reduced conduction reserve. J Physiol 580: 543-560, 2007.
26. Otake H, Suzuki H, Honda T, Maruyama Y. Influences of autonomic nervous system on atrial arrhythmogenic substrates and the incidence of atrial fibrillation in diabetic heart. Int Heart J 50: 627-641, 2009.
27. Pacher P, Ungvari Z, Nanasi PP, Kecskemeti V. Electrophysiological changes in rat ventricular and atrial myocardium at different stages of experimental diabetes. Acta Physiol Scand 166: 7-13, 1999.
28. Pruvot EJ, Katra RP, Rosenbaum DS, Laurita KR. Role of calcium cycling versus restitution in the mechanism of repolarization alternans. Circ Res 94: 1083-1090, 2004.
29. Roberts-Thomson KC, Stevenson I, Kistler PM, Haqqani HM, Spence SJ, Goldblatt JC, Sanders P, Kalman JM. The role of chronic atrial stretch and atrial fibrillation on posterior left atrial wall conduction. Heart Rhythm 6: 1109-1117, 2009.
30. Rosenbaum DS, Jackson LE, Smith JM, Garan H, Ruskin JN, Cohen RJ. Electrical alternans and vulnerability to ventricular arrhythmias. N Engl J Med 330: 235-241, 1994.
31. Sanders P, Morton JB, Davidson NC, Spence SJ, Vohra JK, Sparks PB, Kalman JM. Electrical remodeling of the atria in congestive heart failure: electrophysiological and electroanatomic mapping in humans. Circulation 108: 1461-1468, 2003.
32. Satoh T, Zipes DP. Cesium-induced atrial tachycardia degenerating into atrial fibrillation in dogs: atrial torsades de pointes? J Cardiovasc Electrophysiol 9: 970-975, 1998.
33. Shimoni Y, Firek L, Severson D, Giles W. Short-term diabetes alters K currents in rat ventricular myocytes. Circ Res 74: 620-628, 1994.
34. Tsai CT, Chiang FT, Tseng CD, Yu CC, Wang YC, Lai LP, Hwang JJ, Lin JL. Mechanical stretch of atrial myocyte monolayer decreases sarcoplasmic reticulum calcium adenosine triphosphatase expression and increases susceptibility to repolarization alternans. J Am Coll Cardiol 58: 2106-2115, 2011.
35. Verheule S, Sato T, Everett Tt Engle SK, Otten D, Rubart-von der Lohe M, Nakajima HO, Nakajima H, Field LJ, Olgin JE. Increased vulnerability to atrial fibrillation in transgenic mice with selective atrial fibrosis caused by overexpression of TGF-beta1. Circ Res 94: 1458-1465, 2004.